Obsolete

Retrieves data from different microarray databases using MAGE-ML and for combining microarray data with breast cancer image analysis and clinical data for correlation studies. MAGE-ML provides the necessary data integration to move microarray research from basic biological sciences to clinical applications. The framework has been used to develop a testbed integrated database application to identify genomic and imaging markers for diagnosis of breast cancer.

User report

×
Vote up tools and offer feedback
Give value to tools and make your expertise visible

0 user reviews

0 user reviews

No review has been posted.

MAGE-ML forum

×
Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.

No open topic.

MAGE-ML versioning

×
Upload and version your source code
Get your DOI for better tool traceability. Archive your releases so the community can easily visualize progress on you work.

No versioning.

MAGE-ML classification

MAGE-ML specifications

Software type:
Package/Module
Restrictions to use:
None
Programming languages:
Java
Stability:
Stable
Interface:
Command line interface
Operating system:
Unix/Linux
Computer skills:
Advanced
Maintained:
No

MAGE-ML support

Maintainer

This tool is not maintained anymore.

Credits

×
Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.

Publications

Institution(s)

UCSF Department of Radiology, San Francisco, CA, USA; Harvard Center for Neurodegeneration and Repair (HCNR), Harvard Medical School, Boston, MA, USA; Department of Radiology, Brigham & Women Hospital, Harvard Medical School, Boston, MA, USA; Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA; Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA; Department of Surgery, School of Medicine, University of California, San Francisco, CA, USA

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.